Baxter International, Inc.
One Baxter Parkway
Deerfield
Illinois
60015
United States
Tel: 847-948-2000
Fax: 847-948-3642
Website: http://www.baxter.com/
About Baxter International, Inc.
Baxter touches millions of lives every day. Our products and services are essential building blocks of healthcare.
You’ll find Baxter’s products and therapies on nearly every floor, in every department, in almost every hospital worldwide. You’ll find us in clinics and in the home. Patients and providers rely on Baxter for lifesaving renal and medical products, including intravenous (IV) solutions, systems and administrative sets, IV infusion parenteral nutrition, perioperative care, pharmacy devices and software, acute renal care, and home and in-center dialysis.
Our mission to save and sustain lives inspires our work and our commitment to expanding access to care, providing cost-effective healthcare solutions, delivering quality products and advancing innovations for the world.
Our commitment to our mission means we are there when patients and healthcare professionals need us, during the critical moments that matter most.
YEAR FOUNDED:
1931
LEADERSHIP:
CEO: José (Joe) E. Almeida
CMO: James R. Gavin III
CTO: Uma Chowdhry
CFO: Peter Hellman
PRODUCTS:
All Products
FOLLOW BAXTER INTERNATIONAL:
Tweets by Baxer International
963 articles about Baxter International, Inc.
-
Baxter Recognized With Highest Achievement on 2019 Diversity Best Practices Inclusion Index
7/30/2019
One of 14 organizations to qualify as a Top 10 Percent Inclusion Index Company
-
Baxter Supports Add-on Payment in Proposed ESRD Payment Rule to Spur Innovation for Dialysis Patients
7/30/2019
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today issued this statement
-
Baxter Launches PrisMax in U.S. to Maximize Care for Critically Ill Patients
7/29/2019
Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced today 510(k) clearance of the PrisMax system and integrated TherMax blood warmer, the company’s next-generation platform for continuous renal replacement therapy (CRRT) and therapeutic plasma exchange (TPE).
-
Baxter Adds Finomel With Fish Oil to Ready-to-use Parenteral Nutrition Portfolio
7/29/2019
Baxter International Inc. (NYSE:BAX), a global leader in clinical nutrition, announced today the European launch of Finomel, a ready-to-use triple-chamber bag for parenteral nutrition (PN).
-
Baxter Reports Second-Quarter 2019 Results
7/25/2019
Anticipates $500 million investment to support Advancing American Kidney Health Initiative
-
Baxter Announces U.S. FDA Approval of Myxredlin, The First and Only Ready-To-Use Insulin for IV Infusion
7/22/2019
Offers extended shelf life of 30 days at room temperature or 24 months refrigerated
-
Myxredlin is intended for use only in acute care settings under medical supervision.
-
Baxter Declares Quarterly Dividend Payable October 1, 2019
7/16/2019
The dividend is payable on October 1, 2019, to shareholders of record as of August 30, 2019.
-
Baxter Supports Advancing American Kidney Health Initiative and Plans Significant U.S. Investment to Help Drive Implementation
7/10/2019
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced its full support of the Administration’s Advancing American Kidney Health Initiative introduced today.
-
Baxter Highlights Progress Toward Its 2020 Corporate Responsibility Goals and Efforts to Make a Meaningful Difference Around the World
6/27/2019
Baxter International Inc. (NYSE:BAX), a leading global medical products company, announced today the release of its 2018 Corporate Responsibility Report, which showcases the company’s progress on key initiatives to drive more sustainable operations, enhance product quality, build healthy communities, foster a strong work environment and improve access to healthcare.
-
Baxter Highlights Renal Care Data about Patients’ Health-Related, Quality of Life Outcomes at the 56th ERA-EDTA Congress
6/17/2019
In total, 19 abstracts were presented on Baxter’s therapy options
-
Baxter Leads Hemodialysis Research Consortium for German Federal Ministry of Education and Research
6/14/2019
Baxter International Inc. (NYSE:BAX), a global innovator in renal care, today announced receipt of a major research and development (R&D) grant from the German Federal Ministry of Education and Research (BMBF)’s “From Material to Innovation” program to lead a consortium investigating an anticoagulation-free hemodialysis (HD) option for end-stage renal disease (ESRD) patients
-
Baxter Launches Sharesource 2.0 Telehealth Platform to Support Greater Clinical Insights and Personalized Peritoneal Dialysis Care
6/11/2019
Enhancements designed to give healthcare providers access to more comprehensive treatment data and improve clinic workflow
-
Baxter to Host Second Quarter 2019 Financial Results Conference Call for Investors
6/11/2019
Baxter International Inc. (NYSE:BAX), a leading global medical products company, will host a conference call to discuss its second quarter 2019 financial results on Thursday, July 25, 2019, at 7:30 a.m. Central Time.
-
The Baxter International Foundation Commits $2 Million+ to Operation Smile Care Centers in India
6/4/2019
Grant increases the availability of safe surgical care for cleft conditions
-
Baxter Announces New Research on 3-in-1 Oxiris Set for CRRT and Sepsis Management
5/28/2019
Baxter International Inc. announced that the peer-reviewed journal Blood Purification published a supplemental issue sponsored by Baxter that features real-world clinical experience with the company’s Oxiris filter, which can be used simultaneously in continuous renal replacement therapy and in the removal of cytokines and endotoxin to aide in the management of acute kidney injury patients with sepsis.
-
Baxter to Conduct Fixed Income Investor Presentations
5/9/2019
Baxter International Inc. announced that representatives of the company will conduct a series of Fixed Income Investor Presentations on Thursday, May 9, 2019.
-
Baxter Named a “Best Company for Multicultural Women” by Working Mother
5/7/2019
Baxter International Inc., a leading global medical products company, announced that it has been named a 2019 Best Company for Multicultural Women by Working Mother magazine.
-
Baxter Increases Dividend and Declares Quarterly Dividend
5/7/2019
The indicated annual dividend rate is now $0.88 per share of common stock.
-
Baxter, NAACP and the Alliance for Home Dialysis Expand Program to Increase Awareness of Kidney Care among African Americans
4/26/2019
Baxter International Inc. (NYSE:BAX), a global leader in renal care, along with the National Association for the Advancement of Colored People (NAACP) and the Alliance for Home Dialysis, today announced that the Dialysis Health Imperative for Access, Choice, and Equity (ACE) program will be expanded for a third year.